Dignitana joins Susan G. Komen® for signature event in Los Angeles

Kicking off Breast Cancer Awareness Month, Dignitana will sponsor the annual Susan G. Komen® Los Angeles County MORE THAN PINK Walk® on 8 October 2022. More than 5,000 breast cancer survivors and supporters will walk in downtown Los Angeles to raise funds for breast cancer research, education, screening, and treatment.  


“Susan G Komen is the leading breast cancer organization in the world, and we share a common commitment to supporting the well-being of breast cancer patients. Our participation in the More Than Pink Walk puts us in front of several thousand active members of the breast cancer community, increasing awareness of DigniCap’s benefits to quality of life and building vital connections with this influential group,” said Dignitana CEO Catarina Mård Löwenadler.  


Southern California has been a primary market for Dignitana since the company first introduced FDA-cleared scalp cooling to the United States in 2015. DigniCap is now available in 17 infusion centers in the Los Angeles area including City of Hope, Cedars-Sinai, UCLA, USC, The Angeles Clinic, Beverly Hills Cancer Center, Providence Health, cCare, Pomona Valley, and Long Beach Memorial. 


The Los Angeles MORE THAN PINK WALK aims to raise $500,000. Since its founding, Komen has funded more than $1 billion in research and invested more than $2.3 billion to provide screening, diagnostics, education, treatment, and psychosocial support to people in communities across the U.S. and in 60 countries worldwide. Dignitana is a proud supporter of Susan G. Komen and their mission to save lives by meeting the most critical needs in communities and investing in breakthrough research to prevent and cure breast cancer. 


Tori's Story | Los Angeles MORE THAN PINK WALK:  https://www.youtube.com/watch?v=IAup4bEkbKk


For More Information Contact 

Melissa Bourestom, Chief Communications Officer,  melissa.bourestom@dignitana.com  +1 469-518-5031

About Dignitana

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001.  Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and US operations based in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB. Learn more at www.dignitana.com or www.dignicap.com